Literature DB >> 19251634

Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.

Masanori Inui1, Yuki Kikuchi, Naoko Aoki, Shota Endo, Tsutomu Maeda, Akiko Sugahara-Tobinai, Shion Fujimura, Akira Nakamura, Atsushi Kumanogoh, Marco Colonna, Toshiyuki Takai.   

Abstract

Osteoclasts, cells of myeloid lineage, play a unique role in bone resorption, maintaining skeletal homeostasis in concert with bone-producing osteoblasts. Osteoclast development and maturation (osteoclastogenesis) is driven by receptor activator of NF-kappaB ligand and macrophage-colony stimulating factor and invariably requires a signal initiated by immunoreceptor tyrosine-based activation motif (ITAM)-harboring Fc receptor common gamma chain or DNAX-activating protein (DAP)12 (also referred to as KARAP or TYROBP) that associates with the cognate immunoreceptors. Here, we show that a third adaptor, YINM costimulatory motif-harboring DAP10, triggers osteoclastogenesis and bone remodeling. DAP10-deficient (DAP10(-/-)) mice become osteopetrotic with age, concomitant with a reduction in osteoclasts. The DAP10-associating receptor was identified as myeloid DAP12-associating lectin-1 (MDL-1), whose physiologic function has not been found. MDL-1-mediated stimulation of osteoclast precursor cells resulted in augmented osteoclastogenesis in vitro. MDL-1 associates with both DAP12 and DAP10 in osteoclasts and bone marrow-derived macrophages, where DAP10 association depends almost entirely on DAP12, suggesting a formation of MDL-1-DAP12/DAP10 trimolecular complexes harboring ITAM/YINM stimulatory/costimulatory motifs within a complex that could be a novel therapeutic target for skeletal and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251634      PMCID: PMC2660769          DOI: 10.1073/pnas.0900463106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

Authors:  A Bouchon; J Dietrich; M Colonna
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

Review 2.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 3.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

Review 4.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

5.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

6.  Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells.

Authors:  J Dietrich; M Cella; M Seiffert; H J Bühring; M Colonna
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

7.  CLEC5A is critical for dengue-virus-induced lethal disease.

Authors:  Szu-Ting Chen; Yi-Ling Lin; Ming-Ting Huang; Ming-Fang Wu; Shih-Chin Cheng; Huan-Yao Lei; Chien-Kuo Lee; Tzyy-Wen Chiou; Chi-Huey Wong; Shie-Liang Hsieh
Journal:  Nature       Date:  2008-05-21       Impact factor: 49.962

8.  Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.

Authors:  Tomonori Kaifu; Jin Nakahara; Masanori Inui; Kenichi Mishima; Toshihiko Momiyama; Mitsuji Kaji; Akiko Sugahara; Hisami Koito; Azusa Ujike-Asai; Akira Nakamura; Kiyoshi Kanazawa; Kyoko Tan-Takeuchi; Katsunori Iwasaki; Wayne M Yokoyama; Akira Kudo; Michihiro Fujiwara; Hiroaki Asou; Toshiyuki Takai
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.

Authors:  Juha Paloneva; Jami Mandelin; Anna Kiialainen; Tom Bohling; Johannes Prudlo; Panu Hakola; Matti Haltia; Yrjo T Konttinen; Leena Peltonen
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  Impaired differentiation of osteoclasts in TREM-2-deficient individuals.

Authors:  Marina Cella; Cecilia Buonsanti; Carey Strader; Takayuki Kondo; Andrea Salmaggi; Marco Colonna
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  36 in total

1.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

2.  TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis.

Authors:  Karel Otero; Masahiro Shinohara; Haibo Zhao; Marina Cella; Susan Gilfillan; Angela Colucci; Roberta Faccio; F Patrick Ross; Steve L Teitelbaum; Hiroshi Takayanagi; Marco Colonna
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

3.  CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.

Authors:  Jasmin Batliner; Maria Michela Mancarelli; Mathias Jenal; Venkateshwar A Reddy; Martin F Fey; Bruce E Torbett; Mario P Tschan
Journal:  Mol Immunol       Date:  2010-11-20       Impact factor: 4.407

4.  Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling.

Authors:  Aleksandra A Watson; Andrey A Lebedev; Benjamin A Hall; Angharad E Fenton-May; Alexei A Vagin; Wanwisa Dejnirattisai; James Felce; Juthathip Mongkolsapaya; Angelina S Palma; Yan Liu; Ten Feizi; Gavin R Screaton; Garib N Murshudov; Christopher A O'Callaghan
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  Monitoring Cell-surface N-Glycoproteome Dynamics by Quantitative Proteomics Reveals Mechanistic Insights into Macrophage Differentiation.

Authors:  Mathias Kalxdorf; Stephan Gade; H Christian Eberl; Marcus Bantscheff
Journal:  Mol Cell Proteomics       Date:  2017-03-23       Impact factor: 5.911

Review 6.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

Review 7.  The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.

Authors:  Jessica A Hamerman; Minjian Ni; Justin R Killebrew; Ching-Liang Chu; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

Review 8.  A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.

Authors:  Mary Beth Humphrey; Mary C Nakamura
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

9.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

10.  IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression.

Authors:  Kyung-Hyun Park-Min; Jong-Dae Ji; Taras Antoniv; Alicia C Reid; Randi B Silver; Mary Beth Humphrey; Mary Nakamura; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.